help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoermann, R.
Right arrow Articles by Derwahl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoermann, R.
Right arrow Articles by Derwahl, M.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 933-938, Copyright © 1994 by Endocrine Society


ARTICLES

Interaction of human chorionic gonadotropin (hCG) and asialo-hCG with recombinant human thyrotropin receptor

R Hoermann, M Broecker, M Grossmann, K Mann and M Derwahl
Medical Department II, Klinikum Grosshadern, University of Munich, Germany.

hCG is a putative thyroid stimulator. The present studies were undertaken to examine its interaction and that of its desialylated variant asialo-hCG with recombinant human TSH (hTSH) receptor (hTSHr). To this end, we transfected a human thyroid carcinoma cell line (HTC) lacking endogenous TSHr with the full-length cDNA of the hTSHr. Unlike the wild type, the transfected cells, termed HTC-TSHr cells, were able to bind bovine TSH (bTSH) with high affinity and increase cAMP production in response to bTSH stimulation. Of the hCG forms, intact hCG displayed a weak activity to inhibit [125I] bTSH binding to HTC- TSHr cells, with 100 mg/L (2.6 x 10(-6) mol/L) producing maximally a 20% inhibition, whereas asialo-hCG achieved half-maximum binding inhibition at a concentration of 8 mg/L (2.3 x 10(-7) mol/L). The inhibitory constant (Ki) of asialo-hCG for recombinant hTSHr was calculated from saturation experiments in the presence of variable doses of bTSH and a fixed concentration of asialo-hCG to be approximately 8 x 10(-8) mol/L. The interaction of asialo-hCG with TSHr was further assessed by studies of the direct binding of the radioactively labeled hormone to both HTC and HTC-TSHr cells. [125I]Asialo-hCG binding to HTC-TSHr cells was 4.7%, compared to 1.5% in the wild-type cells lacking TSHr and was displaceable by bTSH (0.1- 100 IU/L), indicating specific binding of the tracer to TSHr. Functionally, hCG (up to 100 mg/L; 2.6 x 10(-6) mol/L) proved unable to evoke any significant cAMP response over basal values in HTC-TSHr cells, as did asialo-hCG. Asialo-hCG, but not hCG, inhibited bTSH- stimulated adenylate cyclase activity in the cells in a dose-dependent manner. In conclusion, the present data show that intact hCG binds only weakly to HTC-TSHr cells and produces no significant cAMP stimulation, which is at variance with data obtained in FRTL-5 and Chinese hamster ovary-TSHr cells, but in good accord with previous findings in human thyroid membranes. Asialo-hCG, on the other hand, strongly binds to recombinant TSHr and inhibits the cAMP response to bTSH in HTC-TSHr cells, indicating that the desialylated hCG variant directly interacts with the receptor and truly is an antagonist of the hTSHr.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
H. Nagasaki, Z. Wang, V. R Jackson, S. Lin, H.-P. Nothacker, and O. Civelli
Differential expression of the thyrostimulin subunits, glycoprotein {alpha}2 and {beta}5 in the rat pituitary.
J. Mol. Endocrinol., August 1, 2006; 37(1): 39 - 50.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Rodien, N. Jordan, A. Lefevre, J. Royer, C. Vasseur, F. Savagner, A. Bourdelot, and V. Rohmer
Abnormal stimulation of the thyrotrophin receptor during gestation
Hum. Reprod. Update, March 1, 2004; 10(2): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski
Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family
Endocr. Rev., August 1, 1997; 18(4): 476 - 501.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Hoermann, C. Spitzweg, S. Poertl, K. Mann, A. E. Heufelder, and P. M. Schumm-Draeger
Regulation of Intercellular Adhesion Molecule-1 Expression in Human Thyroid Cells in Vitro and Human Thyroid Tissue Transplanted to the Nude Mouse in Vivo: Role of Graves' Immunoglobulins and Human Thyrotropin Receptor
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2048 - 2055.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Grossmann, M. W. Szkudlinski, J. E. Tropea, L. A. Bishop, N. R. Thotakura, P. R. Schofield, and B. D. Weintraub
Expression of Human Thyrotropin in Cell Lines with Different Glycosylation Patterns Combined with Mutagenesis of Specific Glycosylation Sites
J. Biol. Chem., December 8, 1995; 270(49): 29378 - 29385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society